Literature DB >> 22962331

Identification and characterization of distinct C-terminal domains of the human hydroxycarboxylic acid receptor-2 that are essential for receptor export, constitutive activity, desensitization, and internalization.

Guo Li1, Qi Zhou, Yena Yu, Linjie Chen, Ying Shi, Jiansong Luo, Jeffrey Benovic, Jianxin Lu, Naiming Zhou.   

Abstract

The human hydroxycarboxylic acid receptor 2 (HCA₂), also known as GPR109A and HM74a, was first identified as a niacin receptor and has recently received significant attention because of its potential to clinically modify plasma lipids in a favorable manner. Our recent studies have demonstrated that the niacin-induced internalization of HCA₂ receptors is regulated by G protein-coupled receptor kinase (GRK) 2 and arrestin3 and that internalized receptors rapidly recycle back to the cell surface. The investigation presented here used a combination of amino acid deletion and site-directed mutagenesis to identify structural and functional domains within the HCA₂ C terminus and explore their potential roles in receptor phosphorylation, desensitization, and internalization. We first constructed four mutants with deletions of 10 to 15 amino acids each that were distinct from truncated mutants. We successfully identified different domains responsible for receptor export, constitutive activity, desensitization, phosphorylation, and internalization. We also generated a comprehensive series of alanine substitution mutants, replacing conserved serine and threonine residues in the C terminus with alanine residues to pinpoint the key residues that are essential for GRK2-mediated phosphorylation and arrestin3 association. Moreover, we found that a sequence from residues 329 to 343 in the C-terminal tail of HCA₂ plays a crucial role in keeping HCA₂ in an inactive conformation. These data demonstrate the importance of distinct domains within the C terminus of HCA₂ for receptor cell surface expression, desensitization, and internalization and phosphorylation and stabilization of an inactive receptor conformation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22962331      PMCID: PMC3502627          DOI: 10.1124/mol.112.081307

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  52 in total

Review 1.  Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling.

Authors:  S S Ferguson
Journal:  Pharmacol Rev       Date:  2001-03       Impact factor: 25.468

2.  Structural domains of the CB1 cannabinoid receptor that contribute to constitutive activity and G-protein sequestration.

Authors:  J Nie; D L Lewis
Journal:  J Neurosci       Date:  2001-11-15       Impact factor: 6.167

Review 3.  Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors.

Authors:  Roland Seifert; Katharina Wenzel-Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2002-09-06       Impact factor: 3.000

4.  Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-beta-arrestin complexes after receptor endocytosis*.

Authors:  R H Oakley; S A Laporte; J A Holt; L S Barak; M G Caron
Journal:  J Biol Chem       Date:  2001-03-09       Impact factor: 5.157

5.  Truncation of the A1 adenosine receptor reveals distinct roles of the membrane-proximal carboxyl terminus in receptor folding and G protein coupling.

Authors:  Halyna Pankevych; Volodymir Korkhov; Michael Freissmuth; Christian Nanoff
Journal:  J Biol Chem       Date:  2003-05-22       Impact factor: 5.157

6.  Distinct kinetic and spatial patterns of protein kinase C (PKC)- and epidermal growth factor receptor (EGFR)-dependent activation of extracellular signal-regulated kinases 1 and 2 by human nicotinic acid receptor GPR109A.

Authors:  Guo Li; Xiaoyan Deng; Chun Wu; Qi Zhou; Linjie Chen; Ying Shi; Haishan Huang; Naiming Zhou
Journal:  J Biol Chem       Date:  2011-07-18       Impact factor: 5.157

7.  beta -Arrestins regulate protease-activated receptor-1 desensitization but not internalization or Down-regulation.

Authors:  May M Paing; Amy B Stutts; Trudy A Kohout; Robert J Lefkowitz; JoAnn Trejo
Journal:  J Biol Chem       Date:  2001-11-02       Impact factor: 5.157

8.  Molecular identification of nicotinic acid receptor.

Authors:  Takatoshi Soga; Masazumi Kamohara; Jun Takasaki; Shun-ichiro Matsumoto; Tetsu Saito; Takahide Ohishi; Hideki Hiyama; Ayako Matsuo; Hitoshi Matsushime; Kiyoshi Furuichi
Journal:  Biochem Biophys Res Commun       Date:  2003-03-28       Impact factor: 3.575

9.  PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect.

Authors:  Sorin Tunaru; Jukka Kero; Annette Schaub; Christian Wufka; Andree Blaukat; Klaus Pfeffer; Stefan Offermanns
Journal:  Nat Med       Date:  2003-02-03       Impact factor: 53.440

10.  Molecular identification of high and low affinity receptors for nicotinic acid.

Authors:  Alan Wise; Steven M Foord; Neil J Fraser; Ashley A Barnes; Nabil Elshourbagy; Michelle Eilert; Diane M Ignar; Paul R Murdock; Klaudia Steplewski; Andrew Green; Andrew J Brown; Simon J Dowell; Philip G Szekeres; David G Hassall; Fiona H Marshall; Shelagh Wilson; Nicholas B Pike
Journal:  J Biol Chem       Date:  2003-01-09       Impact factor: 5.157

View more
  4 in total

1.  Genetic coding variants in the niacin receptor, hydroxyl-carboxylic acid receptor 2, and response to niacin therapy.

Authors:  Sony Tuteja; Lu Wang; Richard L Dunbar; Jinbo Chen; Stephanie DerOhannessian; Santica M Marcovina; Marshall Elam; Ellis Lader; Daniel J Rader
Journal:  Pharmacogenet Genomics       Date:  2017-08       Impact factor: 2.089

2.  Nicotinic acid timed to feeding reverses tissue lipid accumulation and improves glucose control in obese Zucker rats[S].

Authors:  Tobias Kroon; Tania Baccega; Arne Olsén; Johan Gabrielsson; Nicholas D Oakes
Journal:  J Lipid Res       Date:  2016-11-15       Impact factor: 5.922

3.  Dosing profile profoundly influences nicotinic acid's ability to improve metabolic control in rats.

Authors:  Tobias Kroon; Ann Kjellstedt; Pia Thalén; Johan Gabrielsson; Nicholas D Oakes
Journal:  J Lipid Res       Date:  2015-07-13       Impact factor: 5.922

4.  Rare and potentially pathogenic variants in hydroxycarboxylic acid receptor genes identified in breast cancer cases.

Authors:  Cierla McGuire Sams; Kasey Shepp; Jada Pugh; Madison R Bishop; Nancy D Merner
Journal:  BMC Med Genomics       Date:  2021-12-01       Impact factor: 3.063

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.